Company news

GH Research PLC news in 2025

GH Research PLC's news releases, calls and decks from 2025, newest first.

View company

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates

November 5, 2025

GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress

October 8, 2025

GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates

August 6, 2025

GH Research Announces Global Pivotal Program Plans and Further Development Updates

July 22, 2025

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule

June 19, 2025

GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting

May 14, 2025

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates

May 7, 2025

GH Research Reports Full Year 2024 Financial Results and Provides Business Updates

February 26, 2025

GH Research Announces Pricing of $150 Million Public Offering

February 4, 2025

GH Research Announces Proposed Public Offering

February 2, 2025

GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction

February 2, 2025

GH Research to Provide Update on Phase 2b Trial with GH001 in TRD

January 30, 2025

GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents

January 9, 2025

Decks in 2025